Skip to Content



View full screen / Print PDF » Download PDF ⇩
stand (datum): 29.01.2014
format: 100 x 265 mm
farben: 1/1-farbig schwarz
mat.-nr.: 9000812/11
schriftgröße: 8,24 pt

Potaba 500 mg Capsules
Potassium para-aminobenzoate

(Referred to as Potaba Capsules in the remainder of the leaflet)
- Read all of this leaflet carefully before you start taking
this medicine.
- Keep this leaflet. You may need to read it again.
- If you have any further questions, ask your doctor or
- This medicine has been prescribed for you. Do not pass it
on to others. It may harm them, even if their symptoms are
the same as yours.
- If any of the side effects get serious, or if you notice any
side effects not listed in this leaflet, please tell your doctor
or pharmacist.

In this leaflet:

1. What Potaba Capsules are and what they are used for
2. Before you take Potaba Capsules
3. How to take Potaba Capsules
4. Possible side effects
5. How to store Potaba Capsules
6. Further information

The active ingredient in Potaba Capsules is potassium
para-aminobenzoate. It is used in the treatment of Peyronie’s
disease (the growth of fibrous plaques in the soft tissue of the
penis) and scleroderma (excessive deposits of collagen in the
skin or other organs).
Potaba is an antifibrosis agent. The drug acts by increasing
oxygen uptake at the tissue level.

Potaba is not recommended for children
Do not take Potaba Capsules if you:

• are allergic to potassium para-aminobenzoate or to any of the
other ingredients in this medicine (See section 6. Further
• are taking sulphonamides, e.g. trimethoprim, trimoxazole or
• have severe liver damage.

Take special care with Potaba Capsules if you:

• have problems with your kidney function. Your condition will
need to be carefully monitored by your doctor to ensure you
do not become over-sensitive to the medication, in which
case treatment with Potaba will be stopped. Symptoms of
this include fever, rash and tiredness
• have a known liver disorder or disease.
If any of the above points apply to you, speak to your doctor
or pharmacist before taking Potaba Capsules.

Using other medicines

Please tell your doctor or pharmacist if you are taking or have
recently taken any other medicines, including those obtained
without a prescription.
Please check with your doctor if you are taking any of the
following before taking Potaba Capsules as it can stop them
from working:
• medicines known as sulphonamides, e.g. trimethoprim,
trimoxazole or sulphadimidine.

Taking Potaba with food and drink

Always take Potaba Capsules with food. If you do not, there is
a risk that you may feel slightly sick.
If, for any reason, you are not eating, or are just eating very
small amounts, it is advisable that you interrupt treatment with
Potaba Capsules until you start eating normally again. It is
possible that if you do not interrupt treatment the levels of
sugar in your blood may become too low and you may feel
In the elderly, the hypoglycaemia that may occur during
periods of low food intake may be more difficult to recognise
and may cause more neurological symptoms.

Pregnancy and breast feeding

You should not take Potaba Capsules if you are pregnant or
trying to become pregnant without first discussing this with
your doctor.

Do not take Potaba Capsules if you are breast feeding without
talking to your doctor first.
Ask your doctor or pharmacist for advice before taking any

Driving and using machines

Potaba Capsules should not affect your ability to drive or
operate machinery.
However, if you feel confused, sleepy or weak whilst taking
your medicine do not drive or operate machinery until these
symptoms have gone.

Always take Potaba Capsules exactly as your doctor has told
you. Ask your doctor or pharmacist if you are not sure.

Not recommended for use in children.
• The usual dosage is six capsules, four times a day, the
dose being straight after breakfast.
• The dosage should be spread throughout the day as evenly
as possible, to maintain the level of medicine in your system,
making sure you swallow the medicine with food.
• Potaba Capsules should be taken for as long as your doctor
has recommended.

Information for patients with liver problems

If you have liver disorder or disease your doctor may want to
carry out regular tests on your liver function.

If you take more Potaba Capsules than you should

If you take too much Potaba Capsules contact your doctor or
the nearest hospital casualty department immediately.
Treatment for overdose will depend on the symptoms that are

If you forget to take Potaba Capsules

If you miss a dose, wait until the next time you should take
Potaba Capsules and take this dose as normal. Do not take a
double dose to make up for a forgotten dose.
If you have any further questions on the use of this product,
ask your doctor or pharmacist.

Like all medicines Potaba Capsules can cause side effects,
although not everybody gets them.
Low levels of blood sugar (hypoglycemia) can occur if treatment
with Potaba Capsules is continued during periods of low food
intake. Symptoms include hunger, shaking, feeling nervous,
anxious or confused, sweating, dizziness or feeling light-headed,
sleepiness, difficulty in speaking or weakness.
Rarely people have experienced changes in the way the liver
works, shown by blood tests.
If any of the side effects get serious, or if you notice any side
effects not listed in this leaflet, please tell your doctor or

Keep out of the reach and sight of children

• Do not use Potaba Capsules after the expiry date which is
stated on the carton. The expiry date refers to the last day
of that month.
• Do not store above 25 °C.
• Store in the original packaging.
Medicines should not be disposed of via waste water or
household waste. Ask your pharmacist how to dispose of
medicines no longer required. These measures will help to
protect the environment.

What Potaba Capsules contain

The active ingredient in Potaba Capsules is potassium paraaminobenzoate.
The capsules contain gelatine (E441). There are no other
ingredients contained within Potaba Capsules.

What Potaba Capsules look like and the contents of the pack

Potaba Capsules are white gelatine capsules marked ”POTABA-51“.
Each pack contains 240 capsules.

Marketing Authorisation Holder and Manufacturer

CHEPLAPHARM Arzneimittel GmbH, Bahnhofstr. 1a,
17498 Mesekenhagen, Germany.
Product License Number: PL 27041/0004
The leaflet was last revised in January 2014.


Expand view ⇕

Source: Medicines and Healthcare Products Regulatory Agency

Disclaimer: Every effort has been made to ensure that the information provided here is accurate, up-to-date and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. This information has been compiled for use by healthcare practitioners and consumers in the United States. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective or appropriate for any given patient. If you have questions about the substances you are taking, check with your doctor, nurse or pharmacist.